Format

Send to

Choose Destination
Am J Physiol Renal Physiol. 2014 Dec 1;307(11):F1198-206. doi: 10.1152/ajprenal.00327.2014. Epub 2014 Sep 18.

Endothelial dysfunction and oxidative stress in polycystic kidney disease.

Author information

1
Department of Anesthesiology, University of Colorado, Aurora, Colorado; Division of Renal Diseases and Hypertension, University of Colorado, Aurora, Colorado; and Jelena.Klawitter@ucdenver.edu.
2
Division of Renal Diseases and Hypertension, University of Colorado, Aurora, Colorado; and.
3
Department of Anesthesiology, University of Colorado, Aurora, Colorado;
4
Division of General Internal Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.

Abstract

Cardiovascular disease (CVD) is the leading cause of premature mortality in ADPKD patients. The aim was to identify potential serum biomarkers associated with the severity of ADPKD. Serum samples from a homogenous group of 61 HALT study A ADPKD patients [early disease group with estimated glomerular filtration rate (eGFR) >60 ml·min(-1)·1.73 m(-2)] were compared with samples from 49 patients from the HALT study B group with moderately advanced disease (eGFR 25-60 ml·min(-1)·1.73 m(-2)). Targeted tandem-mass spectrometry analysis of markers of endothelial dysfunction and oxidative stress was performed and correlated with eGFR and total kidney volume normalized to the body surface area (TKV/BSA). ADPKD patients with eGFR >60 ml·min(-1)·1.73 m(-2) showed higher levels of CVD risk markers asymmetric and symmetric dimethylarginine (ADMA and SDMA), homocysteine, and S-adenosylhomocysteine (SAH) compared with the healthy controls. Upon adjustments for age, sex, systolic blood pressure, and creatinine, SDMA, homocysteine, and SAH remained negatively correlated with eGFR. Resulting cellular methylation power [S-adenosylmethionine (SAM)/SAH ratio] correlated with the reduction of renal function and increase in TKV. Concentrations of prostaglandins (PGs), including oxidative stress marker 8-isoprostane, as well as PGF2α, PGD₂, and PGE₂, were markedly elevated in patients with ADPKD compared with healthy controls. Upon adjustments for age, sex, systolic blood pressure, and creatinine, increased PGD₂ and PGF₂α were associated with reduced eGFR, whereas 8-isoprostane and again PGF₂α were associated with an increase in TKV/BSA. Endothelial dysfunction and oxidative stress are evident early in ADPKD patients, even in those with preserved kidney function. The identified pathways may provide potential therapeutic targets for slowing down the disease progression.

KEYWORDS:

ADPKD; NO pathway; biomarkers; endothelial dysfunction; oxidative stress

PMID:
25234311
PMCID:
PMC4254971
DOI:
10.1152/ajprenal.00327.2014
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Atypon Icon for PubMed Central
Loading ...
Support Center